Wnt-3a



Wnt-3a

S1SS1Y2YY2P3PP3I4II4W5WW5W6WW6S7SS7L8LL8A9AA9V10VV10G11GG11P12PP12Q13QQ13Y14YY14S15SS15S16SS16L17LL17G18GG18S19SS19Q20QQ20P21PP21I22II22L23LL23C24CC24A25AA25S26SS26I27II27P28PP28G29GG29L30LL30V31VV31P32PP32K33KK33Q34QQ34L35LL35R36RR36F37FF37C38CC38R39RR39N40NN40Y41YY41V42VV42E43EE43I44II44M45MM45P46PP46S47SS47... and 287 more residue(s)...... and 287 more residue(s)

SMILES None
InChIKey None
Sequence SYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

Wnt-3a

S1SS1Y2YY2P3PP3I4II4W5WW5W6WW6S7SS7L8LL8A9AA9V10VV10G11GG11P12PP12Q13QQ13Y14YY14S15SS15S16SS16L17LL17G18GG18S19SS19Q20QQ20P21PP21I22II22L23LL23C24CC24A25AA25S26SS26I27II27P28PP28G29GG29L30LL30V31VV31P32PP32K33KK33Q34QQ34L35LL35R36RR36F37FF37C38CC38R39RR39N40NN40Y41YY41V42VV42E43EE43I44II44M45MM45P46PP46S47SS47... and 287 more residue(s)...... and 287 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.